-PainCare-

###########
■ General Assembly 2021 ■

GA21_group foto


On the 2nd to 4th March 2021, the IMI-PainCare consortium held its annual General Assembly, conducted as a virtual meeting owed to the Covid-19 pandemic. About half way into the funding period, more than 70 consortium members together with IMI scientific officer Elisabetta Vaudano, the external ethics and scientific advisors, discussed exciting achievements and ongoing activities.

Read More…

###########
■ IMI-PainCare at WCE2021 VIRTUAL on 9th of March ■


WCE21_virtual

Representatives of subproject TRiPP will give insights into IMI PainCare at the next WCE2021 VIRTUAL, the 14th World Congress on Endometriosis (6-10 March).
Two presentations on 9th of March will outline the work of IMI PainCare: Read More…

###########
■ Review of 2020 and Engagement of Patient Organisations ■

The International Painful Bladder Foundation has published an updated overview of the project. See this review here.

Read More…

###########
■ IMI-PainCare on Euroanaesthesia 2020 ■

Euroanaesthesia-2020
It’s all about patient reported outcome measures. Subproject PROMPT will present first findings on the virtual Euroanaesthesia congress on 28/29 November 2020. Read More…

###########
■ Join our virtual topical workshop on 5th November 2020 ■

iasp
We are glad to announce our virtual topical workshop “Large-scale Research Consortia in Pain: Experiences in Europe, USA and Japan”. Together with speakers from the USA and Japan, we will be sharing our experiences with building IMI-PainCare and current pain R&D initiatives in the USA and Japan and highlighting their recent progress. Read More…

###########
■ Managing pain ■

Recent news from subproject TRiPP:
We recently worked with Health Awareness on the 2020 Managing Pain campaign. A printed publication was enclosed within every copy of the New Scientist magazine and the content is available online at https://bit.ly/34sqgfq The campaign featured exclusive content from key thought leaders and industry about living with chronic pain on a daily basis and the challenges of diagnosing and treating the pain associated with conditions such as Endometriosis and Interstitial Cystitis/Bladder Pain Syndrome.

###########
■ IMI-PainCare meets EQIPD ■

The need of quality standards in preclinical research is a topic gaining attention in the last years, especially in translational research. The IMI-PainCare consortium have reached out another IMI initiative: European Quality in Preclinical Data (EQIPD; https://quality-preclinical-data.eu/) to collaborate in assessing the study design and data analysis for our studies within subgroups BioPain and TRiPP. This collaboration will ensure equivalent quality standards in preclinical research among the project members, allowing for a successful reproducibility, reducing failure rates and the time and costs associated. IMI-Pain Care welcomes EQIPD to the team and looks forward to the outputs of this collaboration.

###########
■ INTEGRATE-PAIN, a transatlantic US-European interaction in pain research between the NIH HEAL InitiativeSM and the IMI-PainCare consortium ■

Innovations in pain management are needed to reduce the suffering of many people who cannot be treated adequately with current therapies. As lack of effective and safe pain management is a societal problem, it is in the interests of all stakeholders to interact closely to improve the situation. The NIH HEAL and IMI-PainCare teams realized the congruency of their approaches, which strongly supports that valuable synergies will arise from a transatlantic consensus. Dedicated to improving the understanding, management, and treatment of pain, both teams have prioritized common opportunities in preclinical and clinical research, ultimately accelerating the discovery and development of new non-addictive treatments and improving the management of pain.

Together, we established INTEGRATE-Pain, the “IMI-NIH Transatlantic Emphasis Group on Research And Translation-to-care Efforts for Pain”. Our objectives are transatlantic knowledge sharing, harmonizing of standards, combination of infrastructures, coordination of data collection to improve the statistical power of data interpretation in future meta-analyses, and joint dissemination.

On August 5th and 6th 2020, INTEGRATE-Pain will have virtual meetings, originally planned as personal appointments during the IASP 2020 World Pain Congress.

The NIH HEAL Initiative:
The Helping to End Addiction Long-termSM Initiative, or NIH HEAL InitiativeSM, is an aggressive, trans-agency effort to speed scientific solutions to stem the national opioid public health crisis. Almost every NIH Institute and Center is accelerating research to address this public health emergency from all angles.

The initiative is funding hundreds of projects nationwide. Researchers are taking a variety of approaches to tackle the opioid epidemic through:
  • Understanding, managing, and treating pain
  • Improving treatment for opioid misuse and addiction
More information on the NIH HEAL Initiative: https://heal.nih.gov/.

###########
■ Topical workshop at IASP, 2021 ■

IASP-2021

We are delighted that our proposal for a topical workshop “Development of biomarkers for pain: recent advances from research consortia in Europe, U.S.A. and Japan” has been selected for inclusion in the program of the IASP World congress on Pain.
Together with speakers from the U.S.A. and Japan, we will be talking about the need for biomarkers in pain R&D and clinical practice, ultimately to develop novel approaches and for a paradigm change in pain management.
Recent progress of IMI-PainCare and current pain R&D initiatives in U.S.A. and Japan will be presented in generating a comprehensive set of tools which will expand knowledge about pain targets and pathways.
In addition, we will explain efforts to validate biomarkers which will enable stratification of pain patients to allow more individualized treatments, and discover innovative and objective methods for evaluating the success of pain therapies in real-world clinical practice and in clinical trials (Phase II and III).
Looking forward to meeting you at the congress to discuss and invite you to support and synergize with these initiatives.
For more details see https://iaspworldcongress.pathable.co/meetings/DQEhT9wx5Wt2QXdJJ#/


###########
■ General Assembly, 2020 ■

Eli Lilly, UK, thankfully hosted the IMI-PainCare General Assembly 2020. The meeting offered an exciting platform to present progress achieved in the project over the last period. While the joint sessions resulted in inspiring discussions and cross-fertilizations between the sub-projects PROMPT, BIOPAIN and TRiPP, the F2F meetings of the sub-projects set their focus on their specific topics.

ga20_Lilly

###########
■ Meet us at ESUR19 and SIP19 ■


Follow the progress of IMI-PainCare subproject TRiPP at ESUR19!
Join the presentation of Ana Charrua: Neurothrophins and stress in bladder pain (10th Oct; 17:00; Plenary session 2: Translational research in bladder pain; Auditorium).
ESUR19 (10-12 October 2019 Porto, Portugal)
https://esur.uroweb.org/

Furthermore, the co-leads Petra Bloms-Funke and Rolf-Detlef Treede are at the SIP Symposium on 7th November 2019 in Brussels
https://www.sip-platform.eu/sip-2019
Join Petra's talk on “Working in public-private partnerships to improve clinical pain management” in the panel „Pain Research - SIP Joint Statement implementation (Malta)“ Read More…

###########
■ up-coming conferences important for IMI-PAINCARE ■

We have put together an overview on the up-coming conference in 2019 and 2020.
You may download it as a PDF here.


Read More…

###########
■ Meet us at EFIC in Valencia ■

EFIC-2019-website-banner Read More…

###########
■ TRiPP attends International Continence Society meeting ■



Screen Shot 2019-07-29 at 11.11.53

Members of the subproject TRiPP will be attending at the 49th annual meeting of the ICS 2019 in Gothenburg/Sweden (3-6/09/2019).
You are kindly invited to join the oral session of the consortium member Francisco Cruz:
Thursday 5th September 2019; 14:15 - 14:22; Hall G1 / Scientific Podium Short Oral Session 21
Title: Early life stressful events induce chronic bladder pain in adulthood – involvement of TRPV1
Authors: Matos R, Cruz F, Charrua A

See details at: https://www.ics.org/2019



Read More…

###########
■ Project status on SIP platform ■

Project lead Petra Bloms-Funke published a short overview about the status of IMI-PainCare entitled "WHAT HAS HAPPENED SINCE IMI PAIN CARE WAS LAUNCHED?"

Screen Shot 2019-07-29 at 11.07.32


Read More…

###########
■ PROMPT team at Euroanaesthesia in Vienna ■

Team members of the subproject PROMPT meet at Euroanaesthesia 2019 in Vienna.
PROMPT consortium members as well as colleagues from hospitals that participate in the PROMPT NIT-1 study are kindly invited to join the PROMPT meeting at Euroanaesthesia. Read More…

###########
■ IMI-PainCare at IASP in Boston ■

The 17th World Congress on Pain will take place from September 12-16, 2018 in Boston. Several consortium members will present and there is booth organised by us. Your are welcome to drop by!


IASP Presenting-Social Graphics_040618_Facebook 940 x 788

Read More…

###########
■ Public-private partnership tackles major challenges in the care of pain patients ■

To improve the care of patients with acute or chronic pain, a consortium from academia, small and medium-sized enterprises (SMEs), pain societies, patient organizations and pharmaceutical industry launched the research project “IMI-Pain Care – Improving the care of patients suffering from acute or chronic pain” on 1st April. The consortium strives to develop a toolbox that can streamline the research and development process for novel analgesic drugs and improve treatment quality in clinical practice. The project comprises three sub-projects across all phases of the pharmaceutical value chain – from early research to clinical practice – addressing major challenges in the care of patients suffering from acute or chronic pain in a complementary manner. It is anticipated that tools will be validated that will allow patient stratification and enrichment as recommended by the recent EMA/CHMP/970057/2011 guideline on pain treatment. Read More…